Publication
Bailout Intravenous Esmolol for Heart Rate Control in Cardiac Computed Tomography Angiography
dc.contributor.author | Rosa, S | |
dc.contributor.author | Ramos, R | |
dc.contributor.author | Marques, H | |
dc.contributor.author | Santos, R | |
dc.contributor.author | Leal, C | |
dc.contributor.author | Casado, H | |
dc.contributor.author | Saraiva, M | |
dc.contributor.author | Figueiredo, L | |
dc.contributor.author | Cruz Ferreira, R | |
dc.date.accessioned | 2017-11-06T12:25:08Z | |
dc.date.available | 2017-11-06T12:25:08Z | |
dc.date.issued | 2016-12 | |
dc.description.abstract | OBJECTIVE: To evaluate the efficacy and safety of a heart rate (HR) reduction protocol using intravenous esmolol as bailout for failed oral metoprolol regimens in patients undergoing coronary computed tomography angiography (CCTA) with 64-slice multidetector computed tomography (64-MDCT). METHODS: Patients who underwent cardiac 64-MDCT in a single institution between 2011 and 2014 were analyzed. Those with HR above 60 beats per minute (bpm) on presentation received oral metoprolol (50-200 mg) at least one hour before CCTA. Intravenous esmolol 1-2 mg/kg was administered as a bolus whenever HR remained over 65 bpm just before imaging. The primary efficacy endpoint was HR <65 bpm during CCTA. The primary safety endpoint was symptomatic hypotension or bradycardia up to hospital discharge. RESULTS: During the study period CCTA was performed in 947 cases. In 86% of these, oral metoprolol was the only medication required to successfully reduce HR <60 bpm. Esmolol was used in the remaining 130 patients (14%). For esmolol-treated patients mean baseline and acquisition HR were 74±14 bpm and 63±9 bpm, respectively (p<0.001). The target HR of <65 bpm was achieved in 82 of the 130 esmolol-treated patients (63%). Considering the whole population, esmolol use led to a significant increase in the primary efficacy endpoint from 86% to 95% (p<0.001). Esmolol also resulted in a statistically, but not clinically, significant reduction in systolic blood pressure (144±22 to 115±17 mmHg; p<0.001). The combined primary safety endpoint was only observed in two (1.5%) patients. CONCLUSION: Despite optimal use of oral beta-blockers, 14% of patients needed intravenous esmolol for HR control. The pre-medication combination of oral metoprolol and on-demand administration of intravenous esmolol was safe and effective and enabled 95% of patients to be imaged with HR below 65 bpm. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Rev Port Cardiol. 2016 Dec;35(12):673-678. | pt_PT |
dc.identifier.doi | 10.1016/j.repc.2016.07.004 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/2779 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier España | pt_PT |
dc.subject | HSM CAR | pt_PT |
dc.subject | HSM IMA | pt_PT |
dc.subject | Adrenergic beta-1 Receptor Antagonists/administration & dosage | pt_PT |
dc.subject | Adrenergic beta-1 Receptor Antagonists/therapeutic use | pt_PT |
dc.subject | Anti-Arrhythmia Agents/administration & dosage | pt_PT |
dc.subject | Anti-Arrhythmia Agents/therapeutic use | |
dc.subject | Coronary Angiography | |
dc.subject | Heart Rate/drug effects | |
dc.subject | Heart Rate/physiology | |
dc.subject | Injections, Intravenous | |
dc.subject | Metoprolol/therapeutic use | |
dc.subject | Multidetector Computed Tomography | |
dc.subject | Propanolamines/administration & dosage | |
dc.subject | Propanolamines/therapeutic use | |
dc.subject | Salvage Therapy | |
dc.subject | Treatment Failure | |
dc.title | Bailout Intravenous Esmolol for Heart Rate Control in Cardiac Computed Tomography Angiography | pt_PT |
dc.title.alternative | Esmolol Endovenoso em Regime Bail Out Para Controlo de Frequência Cardíaca na Tomografia Computorizada Cardíaca | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 678 | pt_PT |
oaire.citation.issue | 12 | pt_PT |
oaire.citation.startPage | 673 | pt_PT |
oaire.citation.title | Revista Portuguesa de Cardiología | pt_PT |
oaire.citation.volume | 35 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |